Pardoll; Drew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pardoll; Drew.The latest application filed is for "t cell regulation".

Company Profile

3.7.17

Pardoll; Drew - Brookeville MD
PARDOLL; DREW - BALTIMORE MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
T Cell Regulation App 20210230275 - Pardoll; Drew ; et al.	2021-07-29
Combination Of Immunotherapy With Local Chemotherapy For The Treatment Of Malignancies App 20210077434 - MATHIOS; DIMITRIOS ; et al.	2021-03-18
Combination of immunotherapy with local chemotherapy for the treatment of malignancies Grant 10,864,180 - Mathios , et al. December 15, 2	2020-12-15
Anti-vsig10 Antibodies And Methods Of Use App 20200270343 - LEVY; Ofer ; et al.	2020-08-27
Combination Of Immunotherapy With Local Chemotherapy For The Treatment Of Malignancies App 20160310453 - MATHIOS; DIMITRIOS ; et al.	2016-10-27
Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3 App 20150050288 - Pardoll; Drew ; et al.	2015-02-19
Treatment Of Th17-mediated Autoimmune Disease Via Inhibition Of Stat 3 App 20110195509 - Pardoll; Drew ; et al.	2011-08-11
Stat3 Antagonists And Their Uses As Vaccines Against Cancer App 20100297061 - Yu; Hua ; et al.	2010-11-25
Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists App 20100040636 - Yu; Hong ; et al.	2010-02-18
Stat3 antagonists and their use as vaccines against cancer Grant 7,638,122 - Yu , et al. December 29, 2	2009-12-29
Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies App 20090304711 - Pardoll; Drew ; et al.	2009-12-10
STAT3 Agonists and Antagonists and Therapeutic Uses Thereof App 20090227489 - Yu; Hua ; et al.	2009-09-10
Flt3 inhibitors for immune suppression App 20090054358 - Small; Donald ; et al.	2009-02-26
Immune Modulation By Regulating Expression Of The "Minor" Gene In Immune Dendritic Cells App 20070196335 - Pardoll; Drew ; et al.	2007-08-23
STAT3 agonists and antagonists and therapeutic uses thereof App 20070072822 - Yu; Hua ; et al.	2007-03-29
Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses App 20040204565 - Schneck, Jonathan ; et al.	2004-10-14
Stat3 antagonists and their use as vaccines against cancer App 20040175369 - Yu, Hua ; et al.	2004-09-09
Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses Grant 6,734,013 - Schneck , et al. May 11, 2	2004-05-11
Stat3 agonists and antagonists and therapeutic uses thereof App 20040052762 - Yu, Hua ; et al.	2004-03-18
Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses App 20020006903 - Schneck, Jonathan ; et al.	2002-01-17
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses Grant 6,268,411 - Schneck , et al. July 31, 2	2001-07-31
Regulation of systemic immune responses utilizing cytokines and antigens Grant 5,904,920 - Dranoff , et al. May 18, 1	1999-05-18
Controlled release of pharmaceutically active substances for immunotherapy Grant 5,861,159 - Pardoll , et al. January 19, 1	1999-01-19
Irradiated tumor cell vaccine engineered to express GM-CSF Grant 5,637,483 - Dranoff , et al. June 10, 1	1997-06-10

Company Registrations

NCAGE Code	6KP47	PARDOLL, DREW
CAGE Code	6KP47	PARDOLL, DREW

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.